UAE’s ABV to invest around $84M in India to create luxury hospital chain

Advert Bhambhani Ventures (ABV) which runs its healthcare services under three key brands—Nucleus Medical and Diagnostics Centre, Lifeline Healthcare and 800 Doctor—is planning to set foot in India by setting up a luxury hospital chain.

It plans to set up luxury hospitals in metro cities and has already set up a unit of Nucleus Medical in India to evaluate the market.

Nucleus Medical Center (NMC) is a part of Nucleus Hospitals Pvt Ltd, a flagship brand of Lifeline Healthcare, Dubai, in India. It offers a range of diagnostic services comprising pathology, radiology, health check-ups, etc and the centre will also have its in-house medical specialists & consultants.

The group is looking at an investment of at least Rs 500 crore for facilities at multiple locations in the country and will have its first hospital in Mumbai, said Advet Bhambhani, executive chairman and chief executive officer, ABV Group, in an interview with Mint.

ABV provides various medical services in West Asia like medical centres, day surgery hospitals and others.

India’s private healthcare market is dominated by corporate hospital chains such as Apollo Hospitals Enterprise Ltd and Fortis Healthcare Ltd besides Narayana Health, Aster DM Healthcare Manipal Health and others.

Dubai-based healthcare major Aster DM Healthcare which runs a hospital chain in Middle East had earlier entered the Indian healthcare market and has a significant presence in Kerala and Maharashtra and plans to expand in the southern and western regions of the country. It is currently in the process of floating an IPO.

(Edited by Joby Puthuparampil Johnson)

Leave Your Comment(s)